Proposes thymic involution is an adaptive strategy, showing altered T cell dynamics in aging populations.
In mammals, the immune system recognizes and combats pathogens while retaining a memory of prior encounters. In the thymus, naïve T cells capable of recognizing specific antigens are generated through random gene rearrangement, ensuring a diverse immune repertoire. However, the production rate of naïve T cells declines with age, typically following an exponential or power-law function—a phenomenon known as thymic involution, which is often regarded as a deterioration of biological function (immunosenescence). In this paper, we propose a novel theory suggesting that thymic involution may represent an adaptive strategy. As individuals age, repeated exposure to diverse pathogens leads to the accumulation of memory T cells, thereby reducing the need for newly generated naïve T cells to combat infections. Moreover, naïve T cells can persist in the periphery and retain the capacity to initiate immune responses against novel antigens. Using Pontryagin’s Maximum Principle, we calculate the optimal schedule of naïve T cell production. The results show that the production rate peaks during a brief period shortly after birth, followed by an exponential decline throughout life, eventually reaching a phase in which naïve T cell production ceases. If peripheral naïve T cells decay very slowly, the optimal strategy may consist of producing all cohorts at birth, with no subsequent production.
No takes yet. Share an insight, caveat, or question.
Iwasa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: